Atlas Trials

Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain

Clinical trial NCT01062113 · COMPLETED

Trial details

NCT number
NCT01062113
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pain
Start date
2010-04-01
Primary completion
2010-08-01
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.